Anthony Johnson

Co-Founder & CEO

Anthony Johnson is an experienced executive with a strong track record of leadership across the healthcare sector. His experience has covered a multitude of areas inclusive of sales, marketing and strategy and business development. Having MORE

Jean-Michel Gries

Head of Research & Development

Jean-Michel is an accomplished drug development executive. Starting as a director of clinical pharmacology at Aventis (and predecessor companies), and he then became the Head of Clinical Pharmacology for Hoffmann-La Roche. He joined Alcon as MORE

Stephen Chang Ph.D.

Senior Vice-President Research

Dr. Stephen Chang serves on the Scientific Advisory Board or Board of Directors for GT Biopharma, Orphesus Therapeutics, Cloak Therapeutics, Aegis Therapeutics and Legacy Therapeutics. Dr. Chang founded Stemgent, Inc. in 2008 and served as MORE

Bassel El-Rayes, MD

Bassel El-Rayes, MD, is the chief clinical research scientist responsible for coordinating and providing high-level direction to the clinical cancer research programs and clinical cancer trials across the Emory campus.  His research is on translational MORE

Leon Bernal-Mizrachi

Co-Founder, CSO

Leon Bernal-Mizrachi, MD, is Associate Professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine. Dr. Bernal serves as the Emory Service Chief of Hematology and Medical Oncology at Grady MORE

Walter Ogier

Advisor

Walter Ogier co-founded the Harvard-affiliated Acetylon Pharmaceuticals (Boston MA, oncology and neurodegeneration) in 2008 and served as its President & CEO until its sale to Celgene in 2016. He subsequently served as founding President & MORE

Robert Easton

Advisor

Bob Easton has been recognized as a thought leader in healthcare business consulting for almost 40 years. He has led strategy development and supervised opportunity assessments for hundreds of clients on 4 continents, including large MORE